Qiagen stock heads into the open after a 1.05% Xetra gain

At the close on September 14, 2026, Qiagen stock finished Xetra trading at 36.91 euros, up 1.05% with an intraday range between 36.53 and 37.06 euros, as Morgan Stanley's higher price target and strategic comments supported the shares.

Qiagen stock closed on Xetra at 36.91 euros on September 14, 2026, recording a 1.05% gain from the prior session. Compared with its previous close of 36.53 euros, the move added 0.38 euros and came within an intraday range between roughly 36.53 and 37.06 euros.

September 14, 2026 in numbers

Qiagen N.V. (ISIN NL0012169213, Xetra: QIA) saw its Xetra-quoted shares finish at 36.91 euros on September 14, 2026, after trading between an intraday low near 36.53 euros and an intraday high around 37.06 euros, with the advance from the previous close of 36.53 euros amounting to 1.05% and occurring on a turnover of just under 60,000 shares, according to Xetra data cited by Ad-hoc-news.de. In the same report, Ad-hoc-news.de noted that Morgan Stanley lifted its price target for Qiagen and issued a buy signal on the shares while Chief Executive Jonathan Pratt provided new strategic details, a combination that helped attract fresh investor interest.

The session left Qiagen trading modestly above its prior close and within a relatively narrow intraday band, while broader European equities were described as slipping under pressure from banks and oil-driven inflation concerns, according to a regional wrap by Reuters. That backdrop suggests Qiagen's gain stood out against a softer tone in European markets.

Conference appearance today

Today, September 16, 2026, Qiagen is scheduled to participate in the Robert W. Baird Global Healthcare Conference, with a company presentation transcript time stamped at 06:35 p.m. GMT on September 15, 2026, per GuruFocus. In addition, a summary of Qiagen's appearances at the Morgan Stanley Global Healthcare Conference and other recent investor events, including Q2 2026 results that exceeded expectations, is compiled by Quartr, underscoring that management messaging at healthcare conferences remains a potential catalyst for Qiagen shares heading into the open today.